Dr. Reddy's Generic Doesn't Infringe Prilosec: Judge

Law360, New York (March 10, 2009, 12:00 AM EDT) -- A federal judge has dismissed AstraZeneca AB’s patent lawsuit against Dr. Reddy’s Laboratories Ltd. over the generic formulation of popular over-the-counter antacid medication Prilosec.

The judge dismissed the case on Tuesday after agreeing with the defendants that Dr. Reddy’s drug used a different form of omeprazole magnesium, the primary ingredient in Prilosec, than what was covered in the AstraZeneca patents. The patents at-issue in the lawsuit cover the OTC version of AstraZeneca’s blockbuster heartburn drug Prilosec.

“It is clear that no dispute of material fact prevents...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.